Scynexis Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Scynexis Contact Number

Contact :: SCYNEXIS, Inc. (SCYX)

8 hours ago Scynexis.com Show details

(201) 884-5485SCYNEXIS, Inc. 1 Evertrust Plaza. 13th Floor. Jersey City, NJ 07302. Phone: (201) 884-5485. If you are interested in one of our career opportunities, please submit your information here.

Category: Contact SupportShow more

Contacts :: SCYNEXIS, Inc. (SCYX)

2 hours ago Ir.scynexis.com Show details

800-937-5449American Stock Transfer & Trust Company, LLC 10150 Mallard Creek Road Suite 307 Charlotte, NC 28262 T: 800-937-5449

Category: Contact SupportShow more

SCYNEXIS Crunchbase Company Profile & Funding

8 hours ago Crunchbase.com Show details

Company Type For Profit. Contact Email [email protected]scynexis.com. Phone Number 9195448697. SCYNEXIS, Inc. operates as a drug discovery and development company in the United States and internationally. It engages in drug discovery, development, and manufacturing projects in various areas, such as antibacterials, antifungals

Founded: 1999

Category: Contact NumberShow more

SCYNEXIS, Inc. (SCYX)

5 hours ago Scynexis.com Show details

021-03-02Our lead asset, ibrexafungerp (formerly known as SCY-078), is a broad-spectrum, IV/oral antifungal agent representing a novel therapeutic class. On June 1, 2021, ibrexafungerp received its first FDA approval with the trade name BREXAFEMME®. Learn more about BREXAFEMME ®. Ibrexafungerp: A Versatile Anti-Infective.

Category: Contact NumberShow more

Contact Scynexis Scynexis ENP Network

9 hours ago Scynexis.enpnetwork.com Show details

Contact Scynexis. We'll respond as quickly as possible, and almost always in less than 24 hours. Send a message to Scynexis. Fields marked with an asterisk ( *) are required.

Category: Contact SupportShow more

Scynexis, Inc. Company Profile Jersey City, NJ

6 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Scynexis, Inc. of Jersey City, NJ. Get the latest business insights from Dun & Bradstreet.

Category: Contact NumberShow more

About Us :: SCYNEXIS, Inc. (SCYX)

Just Now Scynexis.com Show details

(201) 884-5485President and Chief Executive Officer of SCYNEXIS 1 Evertrust Plaza, Jersey City, NJ 07302 (201) 884-5485

Category: Contact NumberShow more

Synexis LLC Company Profile Lenexa, KS Competitors

5 hours ago Dnb.com Show details

(844) 307-0339www.synexis.com. External Website. Opens New Window. Address. 11711 W 79TH St Lenexa , KS , 66214-1497 United States See other locations. Phone. (844) 307-0339. Company Description. Synexis LLC is located in Lenexa, KS, United States and is part of the Medical Equipment and Supplies Manufacturing Industry.

Category: Contact NumberShow more

Scynexis, Inc. in Raleigh, NC Company Information & Reviews

6 hours ago Bizapedia.com Show details

Scynexis, Inc. is a North Carolina Foreign Business Corporation filed On June 5, 2000. The company's filing status is listed as Current-Active and its File Number is 0552322. The Registered Agent on file for this company is Corporation Service Company and is located at 2626 Glenwood Avenue, Suite 550, Raleigh, NC 27608.

Location: NJ

Category: Contact NumberShow more

SCYNEXIS __SCYNEXIS North Carolina business directory.

4 hours ago Bizstanding.com Show details

Registration: Feb 14, 2003 State ID: 78214855 Reg. number: 3329012 Status: 702 - Section 8 & 15-accepted and acknowledged Status date: Nov 17, 2013 Illustration: Typeset: Word(s)/letter(s)/number(s) Attorney: Anthony J. Malutta Kilpatrick Townsend and Stockton LLP Two Embarcadero Ctr 8Th Fl, San Francisco, CA 94111 Employee: Cynthia M Sloan Goods & …

Category: Contact NumberShow more

Diederik Van Niekerk SCYNEXIS ZoomInfo.com

7 hours ago Zoominfo.com Show details

View Diederik Van Niekerk's business profile at SCYNEXIS. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Investor Relations :: SCYNEXIS, Inc. (SCYX)

4 hours ago Ir.scynexis.com Show details

800-937-5449Transfer Agent. American Stock Transfer & Trust Company, LLC 10150 Mallard Creek Road Suite 307 Charlotte, NC 28262 T: 800-937-5449

Category: Contact NumberShow more

Oksana Glaberman SCYNEXIS ZoomInfo.com

4 hours ago Zoominfo.com Show details

View Oksana Glaberman's business profile at SCYNEXIS. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

SCYNEXIS PACIFIC, PTY. LTD. Company Profile Sydney, NEW

8 hours ago Dnb.com Show details

SCYNEXIS PACIFIC, PTY. LTD. has 5 employees at this location and generates $553,000 in sales (USD). D&B Hoovers provides sales leads and sales intelligence data on over 120 million companies like SCYNEXIS PACIFIC, PTY. LTD. around the world, including contacts, financials, and competitor information.

Category: Contact NumberShow more

Privacy Policy :: SCYNEXIS, Inc. (SCYX)

9 hours ago Scynexis.com Show details

If you believe that we might have any Personal Data from a child under 13, please contact us at [email protected]scynexis.com. A Note to Users Outside of the United States. If you are a non-U.S. user of the Sites, by visiting the Sites and providing us with data, you acknowledge and agree that your personal information may be processed for the purposes

Category: Contact NumberShow more

Scynexis, Inc. in Wilmington, DE Company Info & Reviews

6 hours ago Bizapedia.com Show details

Scynexis, Inc. is a Delaware Corporation filed On November 4, 1999. The company's File Number is listed as 3122073. The Registered Agent on file for this company is Corporation Service Company and is located at 2711 Centerville Rd Ste 400, Wilmington, DE 19808.

Location: DE

Category: Contact NumberShow more

Careers :: SCYNEXIS, Inc. (SCYX)

8 hours ago Scynexis.com Show details

Strong customer service skills and ability to work effectively with vendors and sites. Phone Number. Job. Upload your resume Accepted formats: PDF, Word Doc. I understand that SCYNEXIS may use my information to contact me, and I have read and understand SCYNEXIS’s privacy policy. Cancel. 1 Evertrust Plaza, Jersey City, NJ 07302 (201

Category: Contact NumberShow more

SCYNEXIS, Inc. (SCYX) Company Profile & Facts Yahoo Finance

4 hours ago Finance.yahoo.com Show details

See the company profile for SCYNEXIS, Inc. (SCYX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key …

Category: Contact NumberShow more

Meeting Details SCYNEXIS Peer Program Registration

Just Now Scynexisprograms.com Show details

888-982-7299State License Number* Contact Information. First Name* Middle Name. Last Name* Suffix. Specialty* Email. Business Address Line 1* Business Address Line 2. City* State* To report SUSPECTED ADVERSE REACTIONS, contact SCYNEXIS, Inc. at 1-888-982-SCYX (1-888-982-7299) or FDA at 1

Category: Contact NumberShow more

SCYNEXIS Announces OneforTen Reverse Stock Split

2 hours ago Scynexis.com Show details

Accordingly, on July 17, 2020, the number of authorized shares of SCYNEXIS’s common stock will be 100 million shares. As a result of the reverse split, every 10 shares of SCYNEXIS’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.001 per share.

Category: Contact NumberShow more

Scynexis Company Profile Office Locations, Competitors

5 hours ago Craft.co Show details

Scynexis has 27 employees at their 1 location. See insights on Scynexis including office locations, competitors, revenue, financials, …

Category: Contact NumberShow more

Kim Martin General Manager SCYNEXIS ZoomInfo.com

8 hours ago Zoominfo.com Show details

View Kim Martin's business profile as General Manager at SCYNEXIS. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

SCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History

6 hours ago Finance.yahoo.com Show details

SCYNEXIS to Provide a Corporate Update and Report Third Quarter 2021 Financial Results on November 10. JERSEY CITY, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a

Category: Contact NumberShow more

SCYNEXIS Announces Hansoh Pharma’s Application to National

Just Now Finance.yahoo.com Show details

(646) 970-4681CONTACT: SCYNEXIS Investor Relations Irina Koffler LifeSci Advisors Tel: (646) 970-4681 [email protected] Media Relations Gloria Gasaatura LifeSci Communications Tel: (646) 970-4688

Category: Contact NumberShow more

scyxex101_14.htm SEC

4 hours ago Sec.gov Show details

The number of shares of Common Stock a converting Holder will receive will be the number of shares equal to the amount of the Interest Make-Whole Payment to be paid to such Holder, divided by the product of (x) 97% and (y) the simple average of the Daily VWAP of the shares for the ten (10) consecutive Trading Days ending on and including the

Category: Contact NumberShow more

SCYNEXIS Investor Frequently Asked Questions :: SCYNEXIS

7 hours ago Ir.scynexis.com Show details

Ibrexafungerp has received Qualified Infectious Disease Product status for invasive candidiasis and aspergillosis (oral 2014 and IV 2016) and for vulvovaginal candidiasis in 2018.Ibrexafungerp is eligible to receive five extra years of exclusivity, fast track status and priority review (6 months review rather than a standard review of 10 months) for these …

Category: Contact NumberShow more

SCYNEXIS Funding, Financials, Valuation & Investors

7 hours ago Crunchbase.com Show details

SCYNEXIS has raised a total of $191.4M in funding over 4 rounds. Their latest funding was raised on May 14, 2021 from a Post-IPO Debt round. SCYNEXIS is registered under the ticker NASDAQ:SCYX . Their stock opened with $10.00 in its May 9, 2014 IPO. SCYNEXIS is funded by 2 investors.

Category: Contact NumberShow more

SCYNEXIS to Host Ibrexafungerp Hospital Pipeline Update

1 hours ago Finance.yahoo.com Show details

(646) 970-4681For more information, visit www.scynexis.com. CONTACT: Investor Relations Irina Koffler LifeSci Advisors Tel: (646) 970-4681 [email protected] Media Relations Gloria Gasaatura

Category: Contact NumberShow more

SCYX Insider Trading Report SCYNEXIS Inc

7 hours ago Fintel.io Show details

12-17 sec.gov - exhibit 4.1 pursuant to the terms of section 1 of this warrant, all or a portion of this warrant may have been exercised or canceled, and therefore the actual number of warrant shares represented by this warrant may be less than the amounts set forth on the face hereof. any transferee of this warrant should contact scynexis, inc.

Category: Contact NumberShow more

SCYNEXIS, Inc. LinkedIn

1 hours ago Linkedin.com Show details

SCYNEXIS, Inc. 4,496 followers on LinkedIn. Developing Promising Novel Antifungals SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of

Category: Contact NumberShow more

Scynexis Stock Analysis 2021 SCYX Macroaxis

4 hours ago Macroaxis.com Show details

Scynexis has very high historical volatility over the last 90 days: The company reported the previous year's revenue of 12.05 M.Net Loss for the year was (52.86 M) with profit before overhead, payroll, taxes, and interest of 121 K.: Scynexis currently holds about 92.01 M in cash with (36.06 M) of positive cash flow from operations.This results in cash-per-share (CPS) ratio …

Category: Contact NumberShow more

SCYNEXIS Number of Employees 20132021 SCYX MacroTrends

5 hours ago Macrotrends.net Show details

SCYNEXIS number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives

Category: Contact NumberShow more

SCYNEXIS Announces FDA Approval of BREXAFEMME

8 hours ago Finance.yahoo.com Show details

877-705-6003Dial-in Number: 1-877-705-6003 SCYNEXIS plans to also discuss its commercial plans at a virtual Investor Day to be held on June 29 th. contact SCYNEXIS, Inc. at 1-888-982-SCYX

Category: Contact NumberShow more

Analysts Mean recommendation for SCYNEXIS Inc. (SCYX) was

Just Now Investchronicle.com Show details

SCYNEXIS Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.25 on 06/01/21, with the lowest value was $4.90 for the same time period, recorded on 10/07/21.

Category: Contact NumberShow more

Michael Burry dumped just about everything in Q3 to guard

2 hours ago Finance.yahoo.com Show details

Hedge fund manager Michael Burry of “The Big Short” fame has been a busy man lately. In addition to his non-stop shadowing (and shading) of Tesla CEO Elon Musk on Twitter, Burry has also been

Category: Contact NumberShow more

Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates

4 hours ago Nasdaq.com Show details

Scynexis (SCYX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.28 per share a year ago. These figures are

Category: Contact NumberShow more

SCYNEXIS Presents Interim Analysis from FURI at Virtual

5 hours ago Finance.yahoo.com Show details

646-970-4681For more information, visit www.scynexis.com. CONTACT: Investor Relations Irina Koffler Managing Director LifeSci Advisors, LLC 646-970-4681 (w) [email protected] Media Relations

Category: Contact NumberShow more

SCYNEXIS Reports Third Quarter 2021 Financial Results and

3 hours ago Marketscreener.com Show details

(646) 970-4681SCYNEXIS undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. CONTACT: Investor Relations Irina Koffler LifeSci Advisors Tel: (646) 970-4681 [email protected] Media Relations Gloria Gasaatura LifeSci Communications Tel: (646) 970-4688

Category: Contact NumberShow more

IR Calendar :: SCYNEXIS, Inc. (SCYX)

5 hours ago Ir.scynexis.com Show details

4th Congress of the International Society for Infectious Diseases in Obstetrics and Gynecology (ISIDOG) October 16, 2021 • 8:30am CET.

Category: Contact NumberShow more

SCYNEXIS Inc Company Profile and News Bloomberg Markets

9 hours ago Bloomberg.com Show details

Company profile page for SCYNEXIS Inc including stock price, company news, press releases, executives, board members, and contact information

Category: Contact NumberShow more

SCYNEXIS, Inc. (SCYX) Stock Price, News, Quote & History

Just Now Ca.finance.yahoo.com Show details

SCYNEXIS Reports Third Quarter 2021 Financial Results and Provides Corporate Update. BREXAFEMME® (ibrexafungerp tablets) net sales of $0.5 million generated since August, with IQVIA reporting 1,006 prescriptions in partial Q3; momentum is continuing into Q4 with an additional 1,100 prescriptions reported in October.BREXAFEMME is now covered by …

Category: Contact NumberShow more

SCYX: Average Analyst Price Target is $24.36

6 hours ago Stocknews.com Show details

Scynexis Inc's variance in analysts' estimates is lower than 8.34% of all US stocks. Scynexis Inc's number of analysts covering the stock is greater than 98.79% of stocks in the micro market cap category. Scynexis Inc's average analyst price target is greater than 82.79% of stocks in the micro market cap category.

Category: Contact NumberShow more

Scynexis Stock Stock News SCYX Macroaxis

4 hours ago Macroaxis.com Show details

Investors typically determine Scynexis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scynexis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Category: Contact NumberShow more

FDA Approves Brexafemme Shanghai Canbi Pharma Ltd.

4 hours ago Canbipharm.com Show details

FDA Approves Brexafemme (ibrexafungerp) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections . JERSEY CITY, N.J., June 02, 2021 (GLOBE NEWSWIRE) -- Scynexis, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal …

Category: Contact NumberShow more

SCYX Stock Price and Chart — NASDAQ:SCYX — TradingView

8 hours ago Tradingview.com Show details

SCYX has been consolidating into this bullish wedge for months now. With upcoming catalysts, such as the first FDA approval for their ibrexafungerp antifungal in Q1 2021 and other catalyst announcements potentially in Q4 2020, this looks prime for a large break out over $10. I will be buying at any price within this wedge with a target >$20 for

Category: Contact NumberShow more

Why We Desperately Need to Develop New Antifungals

2 hours ago Labiotech.eu Show details

He is hoping that the current global pandemic may help highlight the importance of this area of drug development. “In some of the indications we’re dealing with, without treatment, the mortality rates are 90 to 100%, so the need for new drugs here is really desperate.”. Although antifungal resistance is slower to develop than

Category: Contact NumberShow more

Contact Caliber Home Loans, Inc.

2 hours ago Caliberhomeloans.com Show details

Caliber Home Loans, Inc. is a mortgage servicer registered with the Superintendent of the New York Department of Financial Services. If you are a customer whose property is located in the state of New York, you may file a complaint and obtain further information about Caliber Home Loans by contacting the New York State Department of Financial Services Consumer …

Category: Contact Support, Home PhoneShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Is scynexis a buy at 18$?

SCYX: Scynexis 2021-03-02 07:30:00 SCYNEXIS Announces Positive Results from Interim Analyses of Ongoing Phase 3 Studies (FURI and CARES), Demonstrating Oral Ibrexafungerp's Ability to Treat Severe Fungal Infections in the Hospital Setting The trend has changed for this stock, it´s a buy and price target is above 18$ and could go far beyond.

When was scynexis founded?

SCYNEXIS was founded in 1999. When did SCYNEXIS become a public company? SCYNEXIS went public in May 2014. Who are the members of SCYNEXIS management team? You can view our management team by visiting the Leadership page on our website. Who are the members of SCYNEXIS Board of Directors?

What does scyx do?

SCYNEXIS, Inc. (NASDAQ: SCYX) is a publicly traded biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant.

How did scynexis perform in Q3 2020?

The current convertible debt offering completed by SCYNEXIS allowed the Company to retire in full its existing $15 million loan, that was set to be repaid by the end of the third quarter 2020. As a result, the Company was able to lower its interest expenses and to push out near-term principal payment obligations.

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea